Miltann en es it fr

Miltann Brand names, Miltann Analogs

Miltann Brand Names Mixture

  • No information avaliable

Miltann Chemical_Formula

C20H23NS

Miltann RX_link

No information avaliable

Miltann fda sheet

Miltann msds (material safety sheet)

Miltann Synthesis Reference

No information avaliable

Miltann Molecular Weight

309.469 g/mol

Miltann Melting Point

< 25 oC

Miltann H2O Solubility

Soluble as HCl salt

Miltann State

Liquid

Miltann LogP

5.7

Miltann Dosage Forms

Tablets (oral, 1 mg)

Miltann Indication

Used for the symptomatic treatment of parkinsonism.

Miltann Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Miltann Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Miltann side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Miltann Patient Information

Miltann Organisms Affected

Humans and other mammals